Didžioji Britanija -
anglų -
MHRA (Medicines & Healthcare Products Regulatory Agency)
granisetron 1mg tablets
a a h pharmaceuticals ltd - granisetron hydrochloride - oral tablet - 1mg
Didžioji Britanija -
anglų -
MHRA (Medicines & Healthcare Products Regulatory Agency)
granisetron 1mg tablets
alliance healthcare (distribution) ltd - granisetron hydrochloride - oral tablet - 1mg
Didžioji Britanija -
anglų -
MHRA (Medicines & Healthcare Products Regulatory Agency)
granisetron 1mg tablets
teva uk ltd - granisetron hydrochloride - oral tablet - 1mg
Didžioji Britanija -
anglų -
MHRA (Medicines & Healthcare Products Regulatory Agency)
granisetron 1mg tablets
sigma pharmaceuticals plc - granisetron hydrochloride - oral tablet - 1mg
Didžioji Britanija -
anglų -
MHRA (Medicines & Healthcare Products Regulatory Agency)
granisetron 1mg tablets
phoenix healthcare distribution ltd - granisetron hydrochloride - oral tablet - 1mg
Didžioji Britanija -
anglų -
MHRA (Medicines & Healthcare Products Regulatory Agency)
granisetron 1mg tablets
cubic pharmaceuticals ltd - granisetron hydrochloride - oral tablet - 1mg
Didžioji Britanija -
anglų -
MHRA (Medicines & Healthcare Products Regulatory Agency)
granisetron 1mg tablets
mawdsley-brooks & company ltd - granisetron hydrochloride - oral tablet - 1mg
Didžioji Britanija -
anglų -
MHRA (Medicines & Healthcare Products Regulatory Agency)
granisetron 1mg tablets
crescent pharma ltd - granisetron hydrochloride - oral tablet - 1mg
Australija -
anglų -
Department of Health (Therapeutic Goods Administration)
granisetron sandoz granisetron (as hydrochloride) 3 mg/3 ml concentrated injection vial
sandoz pty ltd - granisetron hydrochloride, quantity: 3.36 mg (equivalent: granisetron, qty 3 mg) - injection, concentrated - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; citric acid monohydrate; sodium hydroxide - adults: granisetron sandoz injection is indicated for use in adults for: - the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy; - the prevention of nausea and vomiting induced by radiotherapy. children: granisetron sandoz injection is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy.
Australija -
anglų -
Department of Health (Therapeutic Goods Administration)
granisetron sandoz granisetron (as hydrochloride) 1 mg/1 ml concentrated injection vial
sandoz pty ltd - granisetron hydrochloride, quantity: 1.12 mg (equivalent: granisetron, qty 1 mg) - injection, solution - excipient ingredients: sodium chloride; citric acid monohydrate; sodium hydroxide; hydrochloric acid; water for injections - adults: granisetron sandoz injection is indicated for use in adults for: - the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy; - the prevention of nausea and vomiting induced by radiotherapy. children: granisetron sandoz injection is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy.